Cargando…

The Effect of Metalloestrogens on the Effectiveness of Aromatase Inhibitors in a Hormone-Dependent Breast Cancer Cell Model

SIMPLE SUMMARY: Progressive industrialization, urbanization, and consumerism lead to increased contamination of the environment with endocrine-disrupting compounds (EDCs) which play an important role in the increased incidence of hormone-dependent cancers, e.g., breast cancer. EDCs include, among ot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boszkiewicz, Kamila, Moreira, Helena, Sawicka, Ewa, Szyjka, Anna, Piwowar, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856755/ https://www.ncbi.nlm.nih.gov/pubmed/36672406 http://dx.doi.org/10.3390/cancers15020457

Ejemplares similares

Aromatase Inhibitors and Risk of Metabolic and Cardiovascular Adverse Effects in Breast Cancer Patients—A Systematic Review and Meta-Analysis
por: Boszkiewicz, Kamila, et al.
Publicado: (2022)

Nanotoxicology and Metalloestrogens: Possible Involvement in Breast Cancer
por: Wallace, David R.
Publicado: (2015)

Prooxidative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells
por: Moreira, Helena, et al.
Publicado: (2019)

Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells.
por: Macaulay, V. M., et al.
Publicado: (1994)

The Associations between Metalloestrogens, GSTP1, and SLC11A2 Polymorphism and the Risk of Endometrial Cancer
por: Michalczyk, Kaja, et al.
Publicado: (2022)

Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens
por: Howell, Anthony, et al.
Publicado: (2004)

Glyceollins Trigger Anti-Proliferative Effects in Hormone-Dependent Aromatase-Inhibitor-Resistant Breast Cancer Cells through the Induction of Apoptosis
por: Walker, Rashidra R., et al.
Publicado: (2022)

Effect of Interaction between Chromium(VI) with 17β-Estradiol and Its Metabolites on Breast Cancer Cell Lines MCF-7/WT and MDA-MB-175-VII: Preliminary Study
por: Sawicka, Ewa, et al.
Publicado: (2023)

“Metalloestrogenic” effects of cadmium downstream of G protein-coupled estrogen receptor and mitogen-activated protein kinase pathways in human uterine fibroid cells
por: Yu, Linda, et al.
Publicado: (2021)

Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
por: Thanopoulou, Eirini, et al.
Publicado: (2014)

Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer
por: Haque, Reina, et al.
Publicado: (2012)

Effects of Acupuncture on Breast Cancer Patients Taking Aromatase Inhibitors
por: Qi, Qing-ling, et al.
Publicado: (2022)

The Dependence between Urinary Levels of Angiogenesis Factors, 8-Iso-prostaglandin F2α, ɣ-Synuclein, and Interleukin-13 in Patients with Bladder Cancer: A Pilot Study
por: Szymańska, Beata, et al.
Publicado: (2020)

The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer
por: Fabian, C J
Publicado: (2007)

Aromatase Inhibitor-Induced Erythrocytosis in a Patient Undergoing Hormonal Treatment for Breast Cancer
por: Yeruva, Sri Lakshmi Hyndavi, et al.
Publicado: (2015)

Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005)

Effect of Interaction between 17β-Estradiol, 2-Methoxyestradiol and 16α-Hydroxyestrone with Chromium (VI) on Ovary Cancer Line SKOV-3: Preliminary Study
por: Sawicka, Ewa, et al.
Publicado: (2020)

The effects of aromatase inhibitors on lipids and thrombosis
por: Bundred, N J
Publicado: (2005)

The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model
por: Arumugam, Arunkumar, et al.
Publicado: (2014)

Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.
por: Bonnefoi, H. R., et al.
Publicado: (1996)

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
por: Henry, N L, et al.
Publicado: (2013)

SAT-101 The Booster Effect of Aromatase Inhibitor to Overcome Waning Effect of Recombinant Human Growth Hormone
por: Kim, Dae Hyun, et al.
Publicado: (2020)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Clinical utilities of aromatase inhibitors in breast cancer
por: Chumsri, Saranya
Publicado: (2015)

Morphological and Functional Changes in Skin of Adult Male Rats Chronically Treated with Letrozole, a Nonsteroidal Inhibitor of Cytochrome P450 Aromatase
por: Misiakiewicz-Has, Kamila, et al.
Publicado: (2020)

Aromatase inhibitors in men: effects and therapeutic options
por: de Ronde, Willem, et al.
Publicado: (2011)

Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer
por: Cardoso, Debora, et al.
Publicado: (2020)

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health
por: Erbağ, Gökhan, et al.
Publicado: (2015)

Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells
por: Hayashi, Takanori, et al.
Publicado: (2018)

Obesity Impact on Managing Aromatase Inhibitors Side Effects in Breast Cancer Patients
por: Artene, Diana
Publicado: (2022)

Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant
por: Kümler, Iben, et al.
Publicado: (2016)

Chemopreventive activity of celastrol in drug–resistant human colon carcinoma cell cultures
por: Moreira, Helena, et al.
Publicado: (2018)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020)

Anticancer and Antioxidant Activities in Ganoderma lucidum Wild Mushrooms in Poland, as Well as Their Phenolic and Triterpenoid Compounds
por: Kolniak-Ostek, Joanna, et al.
Publicado: (2022)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Aromatase inhibitors in advanced breast cancer: there are efficacy differences
por: Bhatnagar, A S
Publicado: (2005)

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

Short Stature in Chronic Kidney Disease Treated with Growth Hormone and an Aromatase Inhibitor
por: Mendley, Susan R., et al.
Publicado: (2015)

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series
por: Zagouri, F, et al.
Publicado: (2013)

Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer
por: Higuchi, Toru, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q858nm33uu2figuuvqlarpeea5